GlassScriptPhysician profile
Brandan A Kramer
NPI 1639391055
$33,931.08
in general payments reported to CMS, 2019-2025
49 companies · $1,215 in 2025
The $1,215 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,050 · 2020: $739 · 2021: $8,209 · 2022: $13K · 2023: $2,637 · 2024: $4,156 · 2025: $1,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $3,023 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $3,023.14 |
| Education | $185.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27,762.76 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Advance Xp |
| Astellas Pharma US INC | $842.68 | 2019-2024 | Xtandi, Myrbetriq |
| Antares Pharma, INC. | $537.63 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $536.63 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $484.38 | 2019-2025 | |
| Procept Biorobotics Corporation | $410.07 | 2023-2025 | Aquabeam Robotic System |
| Mevion_medical_systems_inc | $308.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $226.81 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.33 | 2019-2025 | |
| Blue Earth Diagnostics | $213.94 | 2019-2023 | |
| Pfizer INC. | $204.43 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $199.69 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $174.87 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Urovant Sciences INC | $159.19 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $122.30 | 2019-2023 | Xiaflex |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $113.95 | 2023-2025 | Gemtesa |
| Karl Storz Endoscopy-America | $109.13 | 2022 | |
| 180 Medical, INC. | $97.26 | 2019-2022 | |
| Teleflex LLC | $96.70 | 2022-2024 | Urolift |
| Olympus America INC. | $95.40 | 2019-2025 | Itind System, Soltive |
| Progenics Pharmaceuticals, INC. | $89.02 | 2021-2024 | |
| Endo USA, INC. | $88.67 | 2024-2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $74.62 | 2023 | Bard Urinary Drainage Bag |
| Halozyme INC | $69.44 | 2023 | |
| Allergan, INC. | $61.59 | 2019-2021 | |
| Amgen INC. | $58.91 | 2019-2022 | |
| Photocure INC | $42.88 | 2019-2023 | Cysview |
| Urogen Pharma, INC. | $39.18 | 2024 | |
| Cycle Pharmaceuticals INC | $38.85 | 2025 | Venxxiva |
| Janssen Scientific Affairs, LLC | $37.04 | 2019 | |
| Medtronic USA, INC. | $36.54 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $30.03 | 2021-2025 | Prolaris |
| Agiliti Surgical, INC. | $29.59 | 2019 | |
| Cook Medical LLC | $28.65 | 2019-2022 | |
| Telix Pharmaceuticals | $24.61 | 2022 | |
| Tolmar, INC. | $24.39 | 2024 | |
| Aytu Biopharma, INC. | $23.07 | 2019 | |
| Axonics, INC. | $21.39 | 2023 | Axonics |
| Calyxo, INC. | $19.79 | 2025 | Cvac Aspiration System |
| Kerecis Limited | $18.91 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Biotissue Holdings INC. | $18.44 | 2023 | |
| Accord Healthcare, INC. | $17.66 | 2023 | |
| Avadel Specialty Pharmaceuticals, LLC | $16.27 | 2019 | |
| Laborie Medical Technologies Corp. | $15.77 | 2023 | |
| Coloplast Corp | $15.25 | 2020 | |
| Verity Pharmaceuticals INC. | $14.45 | 2025 | Trelstar |
| Alnylam Pharmaceuticals INC. | $14.33 | 2021 | |
| Clarus Therapeutics INC. | $13.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandan Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.